Literature DB >> 13673102

Aldosterone excretion in virilizing adrenal hyperplasia.

R M BLIZZARD, G W LIDDLE, C J MIGEON, L WILKINS.   

Abstract

Entities:  

Keywords:  ADRENOGENITAL SYNDROME; ALDOSTERONE/in urine

Mesh：

Substances：

Year:  1959        PMID： 13673102      PMCID： PMC442100          DOI： 10.1172/JCI103921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  17alpha-hydroxyprogesterone and 21-desoxyhydrocortisone; their metabolism and possible role in congenital adrenal virilism.

Authors:  J W JAILER; J J GOLD; R VANDE WIELE; S LIEBERMAN
Journal:  J Clin Invest       Date:  1955-11       Impact factor: 14.808

2.  Adrenogenital syndrome: uncomplicated and hypertensive forms.

Authors:  A M BONGIOVANNI
Journal:  Pediatrics       Date:  1958-04       Impact factor: 7.124

3.  The physiological basis for a method of assaying aldosterone in extracts of human urine.

Authors:  G W LIDDLE; J CORNFIELD; A G CASPER; F C BARTTER
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

4.  [Increase aldosterone excretion in congenital adrenogenital syndrome; pathogenesis of the syndrome].

Authors:  A PRADER; A SPAHR; R NEHER
Journal:  Schweiz Med Wochenschr       Date:  1955-11-05

5.  Studies in nephrosis: chemical corticoids, salt-retaining factor, and effect of ACTH.

Authors:  M F McCALL; B SINGER
Journal:  J Clin Endocrinol Metab       Date:  1953-10       Impact factor: 5.958

6.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism.

Authors:  J F CRIGLER; S H SILVERMAN; L WILKINS
Journal:  Pediatrics       Date:  1952-10       Impact factor: 7.124

7.  THE RENAL EXCRETION OF ENDOGENOUS CREATININE IN MAN. COMPARISON WITH EXOGENOUS CREATININE AND INULIN.

Authors:  B F Miller; A W Winkler
Journal:  J Clin Invest       Date:  1938-01       Impact factor: 14.808

8.  Electrolyte balances in a male infant with adrenocortical insufficiency and virilism; the effect of desoxycorticosterone acetate and salt therapy with special reference to potassium.

Authors:  H L BARNETT; H McNAMARA
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

9.  Congenital adrenal hyperplasia with pseudohermaphrodism and symptoms of Addison's disease; clinical course following bilateral total adrenalectomy, with metabolic studies, pathologic findings and discussion of etiology.

Authors:  R A LEWIS; R KLEIN; L WILKINS
Journal:  J Clin Endocrinol Metab       Date:  1950-07       Impact factor: 5.958

10.  Endocrine clinic: hypopituitarism following postpartum hemorrhage (Sheehan's Syndrome).

Authors:  W S COPPAGE; G W LIDDLE
Journal:  South Med J       Date:  1958-11       Impact factor: 0.954
View more
  7 in total

1.  CONGENITAL ADRENAL HYPERPLASIA.

Authors:  S RAITI; G H NEWNS
Journal:  Arch Dis Child       Date:  1964-08       Impact factor: 3.791

2.  IMPAIRED ALDOSTERONE PRODUCTION IN "SALT-LOSING" CONGENITAL ADRENAL HYPERPLASIA.

Authors:  G T BRYAN; B KLIMAN; F C BARTTER
Journal:  J Clin Invest       Date:  1965-06       Impact factor: 14.808

3.  ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.

Authors:  A KOWARSKI; J W FINKELSTEIN; J S SPAULDING; G H HOLMAN; C J MIGEON
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

4.  Adrenal disorders II. Congenital virilizing adrenal hyperplasia.

Authors:  L WILKINS
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

Review 5.  The adrenal cortex in childhood.

Authors:  H K Visser
Journal:  Arch Dis Child       Date:  1966-02       Impact factor: 3.791

6.  Aldosterone excretion in normal children and in children with adrenal hyperplasia.

Authors:  M I New; B Miller; R E Peterson
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Plasma aldosterone concentration at delivery and during the newborn period.

Authors:  I Z Beitins; F Bayard; L Levitsky; I G Ances; A Kowarski; C J Migeon
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.